Ahmad Ud Din

View CV 

Bio

Dr. Ahmad Ud Din completed his PhD in 2019. He joined Dr. Andrew Neilson at PHHI where he conducts advanced independent and/or directed research with a focus on the interaction between plant-derived phytochemicals, the human microbiome, and nutrition/health and evaluation of dietary phytochemicals and microbial metabolites in animal models.

His research interests include interplay between gut microbiome dysbiosis and interventions through prebiotics, probiotic and how they relate to different diseases such as cardiovascular diseases (diabetes, obesity, atherosclerosis) and colon cancer using various mouse models. His publications can be found in journals including the Journal of Nutritional Biochemistry, Applied Microbiology and Biotechnology, Biomedicine and Pharmacotherapy, Genes & Disease, Cell Death Discovery, etc. Dr. Din is open to share ideas and work in collaboration. He has wide knowledge in multidisciplinary research area and connecting that to gut microbiome.

Research keywords: Fermentation, Probiotics, Bifidobacterium, Lactobacillus, Gut Microbiome, CVD, Diabetes, Colitis, Atherosclerosis, miRNA, Antibiotic Resistance, Microbial Metabolites. (TMA, TMAO, Colibactin, SCFA, Imidazole Propionate, AHL; AhR/IL-22).

ORCID
ResearchGate
Google Scholar

Publications

• Lacticaseibacillusparacasei BNCC345679 revolutionizes DSS-induced colitis and modulates gut microbiota , FRONTIERS IN MICROBIOLOGY (2024)
• Deciphering Microbiome, Transcriptome, and Metabolic Interactions in the Presence of Probiotic Lactobacillus acidophilus against Salmonella Typhimurium in a Murine Model , ANTIBIOTICS-BASEL (2024)
• Impact of Probiotic Lactiplantibacillus plantarum ATCC 14917 on atherosclerotic plaque and its mechanism , WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2024)
• Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression , FRONTIERS IN PSYCHIATRY (2024)
• Novel Synergistic Probiotic Intervention: Transcriptomic and Metabolomic Analysis Reveals Ameliorative Effects on Immunity, Gut Barrier, and Metabolism of Mice during Salmonella typhimurium Infection , GENES (2024)
• Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder , FRONTIERS IN IMMUNOLOGY (2024)
• A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease , Reviews in Endocrine and Metabolic Disorders (2023)
• Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery , Frontiers in Cellular and Infection Microbiology (2023)
• Oligosaccharides of Polygonatum Cyrtonema Hua ameliorates dextran sulfate sodium-induced colitis and regulates the gut microbiota , Biomedicine & Pharmacotherapy (2023)
• Translational informatics for human microbiota: data resources, models and applications , Briefings in Bioinformatics (2023)

View all publications